These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28065538)

  • 1. Re: Daniel E. Spratt, Herbert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71;37-43: High-dose Radiotherapy and Pelvic Lymph Nodal Irradiation for High-risk Prostate Cancer in the Image-guided Radiotherapy Era.
    Fodor A; Fiorino C; Picchio M; Di Muzio N
    Eur Urol; 2017 Jun; 71(6):e179-e180. PubMed ID: 28065538
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37-43: A Step Forward in the Era of Functional Imaging?
    Alongi F; Mazzola R; Aiello D; Salgarello M
    Eur Urol; 2017 Apr; 71(4):e121-e122. PubMed ID: 27876168
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Filippo Alongi, Rosario Mazzola, Dario Aiello and Matteo Salgarello's Letter to the Editor re: Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37-43. A Step Forward in the Era of Functional Imaging?: Functional Imaging and Micrometastatic Disease: Implications for Radiotherapy Field Design.
    Spratt DE; Zelefsky MJ
    Eur Urol; 2017 Apr; 71(4):e123-e124. PubMed ID: 27836418
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
    Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
    Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65: Salvage Radiotherapy and Hormone Therapy: Change Is Coming, Just Not Quite Yet.
    Spratt DE; Dess RT; Feng FY
    Eur Urol; 2018 Mar; 73(3):e64-e65. PubMed ID: 29111144
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65.
    Ghadjar P; Wiegel T
    Eur Urol; 2018 Mar; 73(3):e63. PubMed ID: 29056471
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16.
    Bensimon L; Suissa S; Azoulay L
    Eur Urol; 2013 Aug; 64(2):e28. PubMed ID: 23619391
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Anatomical Patterns of Recurrence following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer: Z. S. Zumsteg, D. E. Spratt, P. B. Romesser, X. Pei, Z. Zhang, M. Kollmeier, S. McBride, Y. Yamada and M. J. Zelefsky J Urol 2015;194:1624-1630.
    Baumann BC; Guzzo TJ; Christodouleas JP
    J Urol; 2016 Sep; 196(3):961-2. PubMed ID: 27294293
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.
    Kishan AU; Lamb JM; Jani SS; Kang JJ; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):832-9. PubMed ID: 25752398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental Dose to Pelvic Nodal Regions in Prostate-Only Radiotherapy.
    Murthy V; Lewis S; Sawant M; Paul SN; Mahantshetty U; Shrivastava SK
    Technol Cancer Res Treat; 2017 Apr; 16(2):211-217. PubMed ID: 27492806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
    Hsu A; Pawlicki T; Luxton G; Hara W; King CR
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal image guided radiation therapy strategy for organs at risk sparing in radiotherapy of the prostate including pelvic lymph nodes.
    van Nunen A; van der Toorn PPG; Budiharto TCG; Schuring D
    Radiother Oncol; 2018 Apr; 127(1):68-73. PubMed ID: 29501209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.
    Zumsteg ZS; Spratt DE; Romesser PB; Pei X; Zhang Z; Kollmeier M; McBride S; Yamada Y; Zelefsky MJ
    J Urol; 2015 Dec; 194(6):1624-30. PubMed ID: 26165583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to Leah Bensimon, Samy Suissa, and Laurent Azoulay's letter to the editor re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16.
    Spratt DE; Zhang Z; Zelefsky MJ
    Eur Urol; 2013 Aug; 64(2):e29-30. PubMed ID: 23619389
    [No Abstract]   [Full Text] [Related]  

  • 18. Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate--first results of the PLATIN 1 trial.
    Habl G; Katayama S; Uhl M; Kessel KA; Edler L; Debus J; Herfarth K; Sterzing F
    BMC Cancer; 2015 Nov; 15():868. PubMed ID: 26547188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer.
    Supiot S; Rio E; Pacteau V; Mauboussin MH; Campion L; Pein F
    BMC Cancer; 2015 Sep; 15():646. PubMed ID: 26408012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes.
    Ahmed F; Sarkar V; Gaffney DK; Salter B; Poppe MM
    Med Dosim; 2016; 41(3):195-8. PubMed ID: 26994828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.